Influence of large amount of shengmai injection on blood coagulation in patients with chronic heart failure.
- Author:
Li MA
1
;
Lan YANG
;
Tian-duo CHEN
Author Information
- Publication Type:Clinical Trial
- MeSH: Aged; Aged, 80 and over; Blood Coagulation; drug effects; Drug Combinations; Drug Therapy, Combination; Drugs, Chinese Herbal; administration & dosage; therapeutic use; Female; Fibrin Fibrinogen Degradation Products; metabolism; Heart Failure; blood; drug therapy; Humans; Infusions, Intravenous; Male; Middle Aged; P-Selectin; blood; Panax; chemistry; Phytotherapy; von Willebrand Factor; metabolism
- From: Chinese Journal of Integrated Traditional and Western Medicine 2003;23(4):275-277
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the effect of Shengmai Injection (SMI) on blood coagulation in patients with chronic heart failure (CHF).
METHODSSixty patients with CHF were randomly divided into two groups, the 30 patients in the treated group were treated with SMI plus conventional treatment of western medicine, and the 30 in the control group treated with conventional treatment alone. The changes of cardiac function were observed and levels of plasma P-selectin, von Willebrand's factor (vWF) and D-dimer were determined.
RESULTSThe total effective rate and the markedly effective rate in the treated group were higher than those in the control group respectively. The levels of P-selectin, vWF and D-dimer lowered in both groups significantly after treatment, but the effect of lowering was better in the treated group than that in the control group.
CONCLUSIONHypercoagulative state exist in patients with chronic heart failure. SMI could improve the state in patients, which may reduce the occurrence and developing of emboic events to certain extent.
